194 filings
Page 3 of 10
DEFA14A
fk990
31 May 22
Additional proxy soliciting materials
10:30am
8-K
7chgy ks404tbwewiea
12 May 22
Therapeutics Announces First Quarter 2022 Financial Results and Provides
6:20am
424B5
71wn8wk
25 Apr 22
Prospectus supplement for primary offering
4:19pm
8-K
anfxcw7avi
9 Mar 22
Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial
6:05am
8-K
eqwlwqv 82o0n
11 Feb 22
Submission of Matters to a Vote of Security Holders
6:01am
8-K
epdmzunt nkbu6ksz
16 Dec 21
Chemomab Therapeutics Announces Expected Appointment of Dale R. Pfost as Chairman of the Board
4:05pm
8-K
plou3ty9axeanhawh
3 Dec 21
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
8:05am
8-K/A
e5ucmswifdq4o
12 Nov 21
Departure of Directors or Certain Officers
4:05pm
8-K
n9f4 ofv0
12 Nov 21
Chemomab Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
7:44am
8-K
39sa0zip6d2gx6hb 3r
10 Nov 21
Regulation FD Disclosure
5:06pm
8-K
j53xq7i6ncxo35m lkws
8 Nov 21
Departure of Directors or Certain Officers
7:35am
8-K
lonogepd1okjhrtybny9
3 Nov 21
Regulation FD Disclosure
4:06pm
8-K
tfi8 vlhp84knp
26 Oct 21
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
kgz 5ld6e
25 Oct 21
Regulation FD Disclosure
4:02pm